Does Sildenafil Help an Enlarged Prostate?

Sildenafil, best known for treating erectile dysfunction, does appear to help relieve symptoms of an enlarged prostate. Multiple clinical trials have shown that it improves urinary symptom scores, reduces how often men get up at night to urinate, and in some studies boosts urine flow rates. The drug works through a mechanism that relaxes smooth muscle in the prostate and bladder neck, which is the same tissue that tightens up and causes trouble when the prostate grows. But the story is more nuanced than a simple yes, and major urology guidelines have not yet reached consensus on how or when to use it for this purpose.

How Sildenafil Works on Prostate Tissue

The prostate and bladder neck contain a lot of smooth muscle, and when the prostate enlarges, that muscle contracts around the urethra and restricts urine flow. Sildenafil belongs to a class of drugs called PDE5 inhibitors, which block an enzyme that breaks down a molecule involved in keeping smooth muscle relaxed. By blocking that enzyme, sildenafil lets the relaxation signal last longer, loosening the grip of smooth muscle around the urethra.

Lab studies confirm this is not just theoretical. When researchers tested sildenafil directly on human bladder neck tissue that had been made to contract, the drug consistently induced relaxation. That relaxation was blocked when they also added chemicals that interfere with the nitric oxide signaling pathway, confirming that sildenafil’s effect on the bladder neck depends on the same pathway it uses elsewhere in the body.¹ A separate study using animal prostate tissue found the same dependence on nitric oxide, with a nitric oxide donor drug enhancing the relaxation and a nitric oxide blocker inhibiting it.²

This smooth-muscle relaxation is mechanistically similar to what alpha-blocker drugs like tamsulosin do, though the two drug classes hit different targets in the signaling chain. Alpha-blockers work by blocking nerve signals that tell smooth muscle to contract; sildenafil works downstream, amplifying the chemical signal that tells smooth muscle to relax. The result in both cases is a more open urinary passage.

What Happens to Urinary Symptoms

The most consistent finding across clinical trials is an improvement in the International Prostate Symptom Score, a standardized questionnaire that tracks how much trouble a man has with urinary frequency, urgency, weak stream, incomplete emptying, and nighttime urination. In a trial comparing sildenafil to tadalafil (another PDE5 inhibitor), both drugs significantly improved symptom scores and post-void residual urine volume, with sildenafil trending toward a slightly larger reduction in symptoms, though that difference was not statistically definitive.³

A multicenter, placebo-controlled trial that tested different sildenafil doses found that both 25 mg once daily and 25 mg twice daily produced significant improvements in symptom scores compared to placebo. The voiding-related symptoms (weak stream, hesitancy, straining) improved more than storage-related symptoms (urgency, frequency). Quality of life scores improved across all treatment groups.⁴

That same trial also looked specifically at nighttime bathroom trips and found that the 50 mg once-daily dose significantly reduced nocturia compared to placebo. This is worth noting because nocturia is often the symptom that bothers men the most, disrupting sleep and dragging down overall well-being.

Does Urine Flow Actually Improve?

This is where the evidence gets a little messier. Some studies show clear improvements in urine flow rates, while others do not. A study of 38 men with urinary symptoms and enlarged prostates found that after a single dose of sildenafil, peak urine flow rate jumped by an average of about 38%, from roughly 11 to nearly 16 milliliters per second. About three-quarters of the men showed measurable improvement, and average flow rate and voiding time also got better.⁵

Another study looking at the acute effects of sildenafil in men with erectile dysfunction (some of whom also had urinary symptoms) found more modest but still statistically significant improvements in average flow rate and post-void residual urine volume.⁶ However, the placebo-controlled nocturia trial mentioned earlier found no significant change in peak flow rate or post-void residual across any of the sildenafil dose groups.⁴

The discrepancy likely comes down to study design and timing. The studies showing flow-rate improvement often measured the effect shortly after a dose, when drug levels were at their peak. The trial that showed no change measured flow rates over a longer treatment period. It is possible that sildenafil’s effect on urine flow is real but transient, or that the symptom improvements patients report reflect something beyond raw flow rate, like reduced urgency, less straining, and more complete bladder emptying.

How Sildenafil Stacks Up Against Alpha-Blockers

Alpha-blockers like tamsulosin are the most commonly prescribed drugs for enlarged-prostate symptoms. A head-to-head comparison found that after three months, about 81% of patients taking sildenafil showed significant symptom improvement compared to roughly 56% of those taking tamsulosin. The researchers concluded that sildenafil was actually superior in reducing symptom scores in that trial.⁷

That is a striking result, but it is one trial, and the broader body of evidence is less definitive. Most urologists still consider alpha-blockers the first-line choice because the evidence base is larger and the drugs have decades of safety data behind them. Sildenafil’s advantage may be most relevant for men who also have erectile dysfunction, since it treats both problems at once. For a man whose main complaint is urinary difficulty without sexual dysfunction, the case for choosing sildenafil over tamsulosin is harder to make with the current evidence.

Combining Sildenafil with an Alpha-Blocker

Since sildenafil and alpha-blockers work through different pathways, combining them might produce additive benefits. A randomized, double-blind trial tested this by giving one group tamsulosin plus sildenafil and another group tamsulosin plus placebo. After six months, symptom scores improved by about 37% in the combination group versus roughly 20% in the tamsulosin-only group, a significant difference. Erectile function and quality of life also improved more with the combination, and the side-effect profile was comparable between groups.⁸

The catch is blood pressure. Both sildenafil and alpha-blockers lower blood pressure through vasodilation, and combining them can amplify that effect. A hemodynamic study found that sildenafil alone dropped systolic blood pressure by an average of about 11 mmHg while lying down, and the combination of sildenafil plus tamsulosin dropped it by about 14 mmHg, compared to only about 2 mmHg with placebo. The combination also significantly reduced systemic vascular resistance.⁹ For most men, a drop of 11 to 14 mmHg is tolerable, but for someone who already has low blood pressure or takes other blood-pressure-lowering medications, the combination could cause dizziness or fainting, especially when standing up quickly.¹⁰

Effects Beyond Muscle Relaxation

Smooth-muscle relaxation is the most obvious way sildenafil helps, but research suggests the drug may benefit the prostate through at least two other routes. The first is reducing inflammation. Chronic low-grade inflammation is now recognized as a driver of prostate enlargement progression, and PDE5 inhibitors appear to exert a direct anti-inflammatory effect by raising intracellular levels of the same signaling molecule they use for muscle relaxation. A review of the evidence noted that beyond simple vasodilation, PDE5 inhibitors could help restore normal prostate function by acting as anti-inflammatory agents.¹¹

The second route involves protecting the bladder itself. When the prostate blocks urine flow for a long time, the bladder muscle thickens and stiffens in response, eventually becoming less effective at emptying. In a mouse study, animals with surgically created bladder outlet obstruction developed thickened bladder walls, increased fibrosis, and unstable contractions. Treating them with sildenafil significantly reduced bladder weight, decreased muscular thickening, and reduced scarring compared to untreated animals. The threshold at which unstable contractions kicked in also improved, meaning the bladder could fill more before starting to spasm.¹² This is animal data, so it does not directly prove the same thing happens in people, but it suggests sildenafil might protect against the bladder damage that long-standing obstruction causes.

Safety Considerations Worth Knowing

Sildenafil’s side effects are well characterized from its long history treating erectile dysfunction. Headache, flushing, nasal congestion, and indigestion are the most common, and they tend to be mild. The more serious concern for men considering sildenafil for prostate symptoms is cardiovascular. As noted earlier, the blood pressure drop is real, and it can be compounded by other medications. Men who take nitrates for chest pain should never use sildenafil, as the combination can cause a dangerous plunge in blood pressure. This is a hard rule, not a suggestion.

For men who are not on nitrates but are taking an alpha-blocker, the combination requires careful dose timing and medical supervision. Starting at low doses and separating the timing of each drug helps minimize the risk of an excessive blood pressure drop. If you are already on tamsulosin and your doctor adds sildenafil, expect to start at the lowest dose and increase gradually.

Vision changes (a blue tinge to everything) and hearing changes are rare but documented side effects that occasionally worry patients. These are almost always temporary and resolve once the drug clears your system. Priapism, a prolonged and painful erection, is exceedingly rare but is a medical emergency if it occurs.

Why Your Doctor May Not Prescribe It for This

Despite the encouraging trial results, sildenafil is not an approved treatment for enlarged prostate in most countries. Tadalafil, a longer-acting PDE5 inhibitor, is the only drug in this class that has regulatory approval for that indication (in its daily 5 mg formulation). This is not because sildenafil has been shown to be inferior; it is mainly because the pharmaceutical sponsor of tadalafil invested in the large-scale trials needed for regulatory approval, while no similar program was pursued for sildenafil.

Guidelines from major urology organizations reflect this awkward reality. A review of the evidence noted that American and European urology guidelines actually present conflicting recommendations about using PDE5 inhibitors with alpha-blockers for prostate symptoms.¹³ The European Association of Urology is more favorable toward PDE5 inhibitors as a treatment option, while the American Urological Association has been more cautious, partly because the larger approved trials used tadalafil rather than sildenafil.

Cost is another practical factor. Generic sildenafil has become inexpensive, which is actually an argument in its favor from a patient perspective but works against it from a regulatory one. No company has strong financial incentive to run the expensive trials that would get generic sildenafil an enlarged-prostate indication. As a result, if your doctor prescribes it for prostate symptoms, it is typically an off-label use.

The Men Most Likely to Benefit

The clearest candidates for sildenafil as a prostate treatment are men who have both urinary symptoms from an enlarged prostate and erectile dysfunction. This overlap is extremely common: studies consistently show that the two conditions share risk factors and frequently coexist, especially in men over 50. For these men, a single drug addressing both complaints is practical and well supported by data.

Men whose most bothersome symptom is nocturia may also be good candidates based on the placebo-controlled trial showing that the 50 mg bedtime dose specifically reduced nighttime bathroom trips. If you are waking up three or four times a night and your current medication is not fully controlling it, this is a conversation worth having with your urologist.

Men who have tried an alpha-blocker without adequate relief represent another group where adding sildenafil could help, given the trial evidence showing the combination outperforms alpha-blocker monotherapy. The blood pressure considerations discussed earlier apply here, and your doctor would need to verify that the combination is safe for you specifically.

On the other hand, men whose urinary symptoms are primarily caused by a very large prostate that is physically compressing the urethra may get less benefit. Sildenafil relaxes muscle, but it does not shrink the gland. For significant prostate volume, a 5-alpha reductase inhibitor like finasteride, which actually reduces prostate size over months, may be more appropriate either alone or in combination.

Sildenafil Versus Tadalafil for Prostate Symptoms

Since tadalafil is the PDE5 inhibitor with actual regulatory approval for enlarged-prostate symptoms, it is fair to wonder how sildenafil compares. The two drugs work through the same mechanism, but tadalafil lasts much longer in the body, roughly 17 to 18 hours versus about 4 to 5 hours for sildenafil. This makes tadalafil better suited to once-daily dosing for a chronic condition, while sildenafil’s shorter duration is part of why it was studied mainly as an on-demand erectile dysfunction drug.

The head-to-head trial mentioned earlier found that both drugs significantly improved symptom scores and post-void residual volume, with sildenafil showing a trend toward slightly greater symptom improvement that did not quite reach statistical significance.³ In practical terms, the two drugs are probably similar in effectiveness for prostate symptoms. The reason tadalafil dominates this space has more to do with pharmacokinetics and business decisions than with superiority in clinical trials.

If you are already taking daily tadalafil for erectile dysfunction, you may already be getting prostate benefits without realizing it. If you prefer sildenafil for erectile dysfunction and also have prostate symptoms, the evidence supports that you are likely getting some urinary benefit from it too, even if that use remains off-label.